Close
Nordic 9Nordic 9

FoRx (private company)

Switzerland forxtherapeutics.com
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth servicesManufacturingPharma
Business model:B2B

FoRx Therapeutics is a Swiss biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 60.87M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to FoRx

Name Criteria
Spain Ability Pharma
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France AbolerIS Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Denmark Acesion Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
60%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 5
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Finland DelSiTech
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden iCellate
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Inbrain Neuroelectronics
60%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Top